Your browser doesn't support javascript.
loading
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE.
Johnston, Stephen R D; Hegg, Roberto; Im, Seock-Ah; Park, In Hae; Burdaeva, Olga; Kurteva, Galina; Press, Michael F; Tjulandin, Sergei; Iwata, Hiroji; Simon, Sergio D; Kenny, Sarah; Sarp, Severine; Izquierdo, Miguel A; Williams, Lisa S; Gradishar, William J.
Afiliación
  • Johnston SRD; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Hegg R; Centro de Referência da Saúde da Mulher, São Paulo, Brazil.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Park IH; National Cancer Center, Gyeonggi-do, Korea.
  • Burdaeva O; Regional Oncology Dispensary, Arkhangelsk, Russia.
  • Kurteva G; University Cancer Center Hospital, Sofia, Bulgaria.
  • Press MF; University of Southern California, Los Angeles, Los Angeles, CA.
  • Tjulandin S; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Iwata H; Aichi Cancer Center Hospital, Aichi, Japan.
  • Simon SD; Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Kenny S; Novartis Pharma AG, Basel, Switzerland.
  • Sarp S; Novartis Pharma AG, Basel, Switzerland.
  • Izquierdo MA; Novartis Pharma AG, Basel, Switzerland.
  • Williams LS; Novartis Pharmaceuticals UK Limited, Frimley, United Kingdom.
  • Gradishar WJ; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.
J Clin Oncol ; 39(1): 79-89, 2021 01 01.
Article en En | MEDLINE | ID: mdl-32822287
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de la Aromatasa / Trastuzumab / Fulvestrant / Lapatinib Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de la Aromatasa / Trastuzumab / Fulvestrant / Lapatinib Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos